PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $61,272,000 | -38.7% | 3,115,008 | 0.0% | 1.08% | -22.1% |
| Q3 2021 | $99,992,000 | -5.2% | 3,115,008 | 0.0% | 1.39% | -18.1% |
| Q2 2021 | $105,443,000 | -9.9% | 3,115,008 | 0.0% | 1.69% | -4.1% |
| Q1 2021 | $117,000,000 | -7.9% | 3,115,008 | -18.6% | 1.76% | -0.7% |
| Q4 2020 | $127,067,000 | -9.4% | 3,825,008 | 0.0% | 1.78% | -30.8% |
| Q3 2020 | $140,263,000 | +11.4% | 3,825,008 | 0.0% | 2.57% | +4.6% |
| Q2 2020 | $125,881,000 | +31.5% | 3,825,008 | +3.2% | 2.45% | -18.9% |
| Q1 2020 | $95,725,000 | -15.7% | 3,707,408 | +1.7% | 3.02% | -12.2% |
| Q4 2019 | $113,562,000 | – | 3,646,808 | – | 3.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $77,669,000 | 45.24% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $218,878,000 | 17.56% |
| Abingworth LLP | 1,203,135 | $45,057,000 | 15.56% |
| Greenspring Associates, LLC | 360,939 | $13,557,000 | 10.78% |
| Penn Mutual Asset Management, LLC | 86,940 | $3,265,000 | 3.69% |
| RA Capital Management | 3,115,008 | $117,000,000 | 1.76% |
| Rhenman & Partners Asset Management AB | 175,000 | $6,573,000 | 0.46% |
| Summit Rock Advisors, LP | 34,100 | $1,281,000 | 0.44% |
| Eventide Asset Management | 600,000 | $22,536,000 | 0.33% |
| Parkman Healthcare Partners LLC | 30,207 | $1,135,000 | 0.26% |